Science Explorer Back to mapMap
Discussion
Topic · Urology

Urological Disorders and Treatments

Urological Disorders and Treatments is a research topic within Urology. Science Explorer counts 53k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers covers a wide range of topics related to urotrauma, genitourinary development, and associated conditions such as hypospadias, urethral stricture disease, bladder exstrophy, endocrine disruption, and penile fracture. It includes discussions on surgical techniques, epidemiological studies, genetic and environmental factors, long-term outcomes of various treatments, and the molecular mechanisms underlying external genitalia development.

  • Urotrauma
  • Genitourinary Development
  • Hypospadias
  • Urethral Stricture Disease
  • Buccal Mucosa Grafts
  • External Genital Development
  • Bladder Exstrophy
  • Endocrine Disruption
  • Penile Fracture
  • Epidemiology
Research works
53k
fractional, since 1950
In the world top 10%
5.3k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-4%
the tick is no change
Largest producer
United States
30% of the 10 largest, 2022-now
Urological Disorders and Treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Urological Disorders and Treatments research?

By volume, the United States and India publish the most (1.4k and 697 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.4k works
  2. 2 India 697 works
  3. 3 China 644 works
  4. 4 United Kingdom 328 works
  5. 5 Germany 322 works
  6. 6 Türkiye 302 works
  7. 7 Japan 277 works
  8. 8 Italy 275 works
  9. 9 France 191 works
  10. 10 Russia 188 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 29.7%India: 15.2%China: 14.0%United Kingdom: 7.2%6 others listed: 33.9%30%largest
United States1,359 · 29.7%India697 · 15.2%China644 · 14.0%United Kingdom328 · 7.2%6 others listed1,556 · 33.9%

Shares of the rows listed above, not of the whole node.

Which institutions lead Urological Disorders and Treatments research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Urological Disorders and Treatments research, followed by University College London and Shanghai Jiao Tong University.

By volume, 2022-now

  1. 1 All India Institute of Medical SciencesIndia 78 works
  2. 2 University College LondonUnited Kingdom 44 works
  3. 3 Shanghai Jiao Tong UniversityChina 40 works
  4. 4 Harvard UniversityUnited States 38 works
  5. 5 Sichuan UniversityChina 29 works
  6. 6 Mayo ClinicUnited States 29 works
  7. 7 Sağlık Bilimleri ÜniversitesiTürkiye 29 works
  8. 8 Johns Hopkins UniversityUnited States 29 works
  9. 9 Capital Medical UniversityChina 24 works
  10. 10 University of TorontoCanada 23 works

Who are the leading researchers in Urological Disorders and Treatments?

The most-cited researchers publishing on Urological Disorders and Treatments include David Moher, George Davey Smith and Bert Vogelstein.

  1. 1 David Moher Canada 898k citations
  2. 2 George Davey Smith United Kingdom 435k citations
  3. 3 Bert Vogelstein United States 373k citations
  4. 4 Hermann Brenner Germany 343k citations
  5. 5 Cyrus Cooper United Kingdom 342k citations
  6. 6 Jun Wang China 340k citations
  7. 7 Wei Huang China 267k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Urological Disorders and Treatments?

The most cited paper in Urological Disorders and Treatments is "Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects: Opinion" (N E Skakkebæk, Ewa Rajpert‐De Meyts, Katharina Maria Main, 2001), with 2,271 citations. Next come "Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial" (2,244) and "Biological, Epidemiological, and Clinical Aspects of Echinococcosis, a Zoonosis of Increasing Concern" (1,983).

Most cited papers
#PaperReleasedCitations
1 Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects: Opinion N E Skakkebæk, Ewa Rajpert‐De Meyts, Katharina Maria Main · Human Reproduction May 2001 2,271
2 Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial Ronald Henry Gray, Godfrey Kigozi, David Serwadda et al. · The Lancet Feb 2007 2,244
3 Biological, Epidemiological, and Clinical Aspects of Echinococcosis, a Zoonosis of Increasing Concern J. Eckert, Peter Deplazes · Clinical Microbiology Reviews Open access 2004 1,983
4 Tissue-engineered autologous bladders for patients needing cystoplasty Anthony Atala, Stuart B. Bauer, Shay Söker et al. · The Lancet Open access Apr 2006 1,845
5 Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors Álvaro Morales, David Eidinger, Andrew W. Bruce · The Journal of Urology 22 Dec 2016 1,538
All 100 most cited papers, with filters and sorting

Where is Urological Disorders and Treatments research done?

The largest centres of Urological Disorders and Treatments research in 2022-now are London (United Kingdom), Istanbul (Türkiye), Beijing (China) and Moscow (Russia).

Largest cities, 2022-now

  1. 1 LondonUnited Kingdom 119 works
  2. 2 IstanbulTürkiye 101 works
  3. 3 BeijingChina 85 works
  4. 4 MoscowRussia 85 works
  5. 5 New DelhiIndia 84 works
  6. 6 New YorkUnited States 65 works
  7. 7 ShanghaiChina 64 works
  8. 8 TokyoJapan 62 works
  9. 9 ParisFrance 56 works
  10. 10 RomeItaly 54 works
See Urological Disorders and Treatments on the map

Where is the best place to study Urological Disorders and Treatments?

Among universities, judged by research, University College London, Harvard University and Sichuan University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 20.26%fractional works in this field (log) →share of work in the world top 10% →Sichuan UniversityHarvard UniversityJohns Hopkins Univer…University College L…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University College LondonUnited Kingdom 73.112.5%4.3×44 +39.5%
2Harvard UniversityUnited States 66.518.1%1.9×38 -10.8%
3Sichuan UniversityChina 66.022.1%2.0×29 +65.4%
4Johns Hopkins UniversityUnited States 65.916.2%2.9×29 +10.8%
5University of TorontoCanada 63.525.9%1.8×23 -15.2%
6Karolinska InstitutetSweden 63.526.5%3.2×11 -8.7%
7All India Institute of Medical SciencesIndia 60.86.5%11.0×78 +37.5%
8University of Naples Federico IIItaly 59.628.3%2.4×11 +26.8%
9Shanghai Jiao Tong UniversityChina 58.121.4%2.2×40 -12.1%
10University of CopenhagenDenmark 57.225.1%1.8×11 +52.3%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Urological Disorders and Treatments, country by country

Is Urological Disorders and Treatments research growing?

Output in 2022-2025 was 4% lower than in 2018-2021, peaking in 2020.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Urological Disorders and Treatments as a percentage of every work published that year, 0.031% in 2024.

still counting0.050%0.10%Urological Disorders and Treatments0.027% in 202519801990200020102020

Fractional works of Urological Disorders and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Urological Disorders and Treatments10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Urological Disorders and Treatments. Posts are plain text and can be reported.